Ojal Pharmaceuticals Private Limited
About Ojal Pharmaceuticals Private Limited
Data last updated:
Ojal Pharmaceuticals Private Limited is a private limited company based in Indore, Madhya Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 18 January 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24290MP2019PTC047557. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹58.56 Lakh. It is led by directors including Giriraj Gupta and Anil Kumar Chopra.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Ch – 11 Kadambri Housing Board Colony Silicon City Rau Road, Indore, Madhya Pradesh, India – 452012.
As per the financials filed for FY 2024, the company reported a revenue of ₹26.15 Lakh, a growth of 39% compared to the previous year. For the same year it recorded a net profit of ₹6,112 (net margin 0.2%) and EBITDA of ₹37,815 (EBITDA margin 1.4%). Revenue has declined at a compounded annual rate (CAGR) of 16% over three years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Ojal Pharmaceuticals Private Limited's registered office is in Indore, Madhya Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressCh – 11 Kadambri Housing Board Colony Silicon City Rau Road, Indore, Madhya Pradesh, India – 452012
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Ojal Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Ojal Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Ojal Pharmaceuticals Private Limited, buy the company report.
Financials of Ojal Pharmaceuticals Private Limited
FY 2024 filings availableOjal Pharmaceuticals Private Limited reported revenue of ₹26.15 Lakh (up 39% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue rose 39% in the latest year, though over three years it has declined at a compounded annual rate (CAGR) of 16%. EBITDA rose 177% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹37,815 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹6,112 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.4% | ||||
| Net Profit Margin | 0.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Ojal Pharmaceuticals Private Limited, buy the company report.
Board of directors of Ojal Pharmaceuticals Private Limited
Ojal Pharmaceuticals has 4 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Giriraj Gupta | Director | 18 Jan 2019 | 7 Years 9 Months | Current |
| Anil Kumar Chopra | Director | 27 Dec 2019 | 6 Years 9 Months | Current |
| Surbhi Gupta | Additional Director | 26 Jul 2024 | 2 Years 2 Months | Current |
| Kirti Shah | Additional Director | 26 Jul 2024 | 2 Years 2 Months | Current |
Auditor
Ojal Pharmaceuticals Private Limited is audited by GARG MODI & ASSOCIATES for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| GARG MODI & ASSOCIATES | FY 2021 | 022821C |
Shareholding
The shareholding of Ojal Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Ojal Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Ojal Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ojal Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Ojal Pharmaceuticals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Ojal Pharmaceuticals Private Limited, buy the company report.
Recent activity
Ojal Pharmaceuticals Private Limited has 5 board changes on record since 2019: 4 appointments and 1 cessation. The latest: Kirti Shah was appointed as Additional Director on 26 Jul 2024.
Frequently asked questions
Ojal Pharmaceuticals is an active private limited company based in Indore, Madhya Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 18 January 2019 (7+ years old) and is registered under CIN U24290MP2019PTC047557.
Ojal Pharmaceuticals has 4 current directors:
- Giriraj Gupta - Director
- Anil Kumar Chopra - Director
- Surbhi Gupta - Additional Director
- Kirti Shah - Additional Director
The latest financial statements of Ojal Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2019 are in the company report.
No. Ojal Pharmaceuticals has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Ojal Pharmaceuticals is U24290MP2019PTC047557. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ojal Pharmaceuticals was incorporated on 18 January 2019, making it 7+ years old. It is registered with the Registrar of Companies, Gwalior.
Kirti Shah was appointed as Additional Director on 26 Jul 2024. Surbhi Gupta was appointed as Additional Director on 26 Jul 2024. Atul Bapna ceased to be Director on 07 Apr 2022. Ojal Pharmaceuticals has 5 board changes on record in total.
The registered office of Ojal Pharmaceuticals is at Ch – 11 Kadambri Housing Board Colony Silicon City Rau Road, Indore, Madhya Pradesh, India – 452012.
Ojal Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Ojal Pharmaceuticals is compliant as of 01 July 2026. The company is actively filing with the Registrar of Companies.